FDA: Reissued Emergency Use Authorization, Pfizer-BioNTech COVID-19 Vaccine (2021)

Government Record · U.S. Food and Drug Administration · May 10, 2021

The FDA's May 2021 reissued emergency use authorization for the Pfizer-BioNTech vaccine, describing it as nucleoside-modified mRNA in lipid particles and listing its ingredients.

The Pfizer-BioNTech COVID-19 Vaccine contains a nucleoside-modified messenger RNA (modRNA) encoding the viral spike glycoprotein of SARS-CoV-2 formulated in lipid particles.

2
Read the document (PDF)Official source

The FDA's May 2021 reissued emergency use authorization for the Pfizer-BioNTech vaccine, describing it as nucleoside-modified mRNA in lipid particles and listing its ingredients.

Election Day is Tuesday, Nov 3. Know who you're voting for: your values vs. their record, with sources.Build my Vote Card →